Name | Number of supported studies | Average coverage | |
---|---|---|---|
squamous epithelial cell | 4 studies | 52% ± 18% | |
epithelial cell | 3 studies | 41% ± 19% |
Insufficient scRNA-seq data for expression of SPRR2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 74% | 26175.45 | 1073 / 1445 | 55% | 1187.65 | 100 / 183 |
tonsil | 0% | 0 | 0 / 0 | 89% | 1166.94 | 40 / 45 |
uterus | 33% | 609.38 | 56 / 170 | 37% | 411.09 | 169 / 459 |
skin | 59% | 320.68 | 1062 / 1809 | 10% | 66.62 | 48 / 472 |
bladder | 48% | 13.86 | 10 / 21 | 10% | 81.83 | 52 / 504 |
lung | 21% | 7.61 | 121 / 578 | 26% | 257.01 | 303 / 1155 |
ovary | 45% | 20.39 | 81 / 180 | 0% | 0 | 0 / 430 |
liver | 36% | 11.61 | 82 / 226 | 0% | 0 | 0 / 406 |
stomach | 35% | 46.90 | 125 / 359 | 1% | 2.13 | 4 / 286 |
kidney | 36% | 17.56 | 32 / 89 | 0% | 0 | 0 / 901 |
pancreas | 33% | 15.85 | 107 / 328 | 3% | 4.80 | 5 / 178 |
spleen | 31% | 10.74 | 75 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 28% | 10.05 | 73 / 258 | 0% | 0.34 | 1 / 230 |
intestine | 22% | 6.85 | 215 / 966 | 5% | 87.15 | 25 / 527 |
prostate | 21% | 7.11 | 52 / 245 | 0% | 0 | 0 / 502 |
breast | 19% | 16.90 | 85 / 459 | 1% | 3.10 | 11 / 1118 |
thymus | 17% | 7.77 | 111 / 653 | 0% | 0.12 | 1 / 605 |
adipose | 17% | 15.87 | 203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 15% | 15.99 | 138 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 14% | 11.74 | 191 / 1335 | 0% | 0 | 0 / 0 |
heart | 13% | 4.82 | 116 / 861 | 0% | 0 | 0 / 0 |
muscle | 12% | 18.58 | 99 / 803 | 0% | 0 | 0 / 0 |
brain | 10% | 4.07 | 261 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0048874 | Biological process | host-mediated regulation of intestinal microbiota composition |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0001533 | Cellular component | cornified envelope |
GO_0030141 | Cellular component | secretory granule |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0030133 | Cellular component | transport vesicle |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
Gene name | SPRR2A |
Protein name | Small proline-rich protein 2A (SPR-2A) (2-1) |
Synonyms | |
Description | FUNCTION: Gut bactericidal protein that selectively kills Gram-positive bacteria by binding to negatively charged lipids on bacterial membranes, leading to bacterial membrane permeabilization and disruption . Specifically binds lipids bearing negatively charged headgroups, such as phosphatidic acid, phosphatidylserine (PS), cardiolipin (CL), and phosphatidylinositol phosphates, but not to zwitterionic or neutral lipids . Induced by type-2 cytokines in response to helminth infection and is required to protect against helminth-induced bacterial invasion of intestinal tissue (By similarity). May also be involved in the development of the cornified envelope of squamous epithelia; however, additional evidences are required to confirm this result in vivo . . |
Accessions | P35326 ENST00000392653.3 |